SEC Form 4 · accession 0001144204-15-016392

Fortress Biotech, Inc. · FBIO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Mar 12, 2015

Accepted (ET)

Mar 16, 2015 · 4:58 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001429260

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock, par value $0.001^F1	Mar 12, 2015	A	50,000	$0.00	A	436,000	D
Common Stock, par value $0.001^F1	Mar 12, 2015	A	50,000	$0.00	A	486,000	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option to purchase Common Stock^F2	$2.10	holding	—	—	—	—	Dec 19, 2023	Common Stock	30,000	30,000	D
Warrants to Purchase Common Stock^F3,F4,F5	$6.15	holding	—	—	—	—	—	Common Stock	3,399	3,399	D
Options to purchase Common Stock^F6	$1.37	holding	—	—	—	—	Oct 5, 2020	Common Stock	25,000	25,000	D
Options to purchase Common Stock^F7	$6.25	holding	—	—	—	—	Feb 10, 2022	Common Stock	15,000	15,000	D
Options to purchase Common Stock^F8	$7.42	holding	—	—	—	—	Feb 7, 2023	Common Stock	15,000	15,000	D

F1One-third of the shares will vest on each of March 12, 2016, 2017 and 2018, and subject to continued service on the board of directors.
F2One-third of the shares will vest on each of December 19, 2014, 2015 and 2016.
F3This warrant was disbursed by Paramount Credit Partners, LLC on October 25, 2011.
F4This warrant is fully vested.
F52,236 shares underlying this warrant expired on January 22, 2014, 417 shares underlying this warrant expire on May 28, 2014, and 746 shares underlying this warrant expire on June 24, 2014.
F6One-third of the shares vested on October 5, 2011, 2012 and 2013.
F7One-third of the shares will vest on each of February 10, 2013, 2014 and 2015.
F8One-third of the shares will vest on each of February 7, 2014, 2015 and 2016.